Caption Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 919 |
|
|
2025
Q1 | – | Sell |
-98,934
| Closed | -$3.82M | – | 976 |
|
|
2024
Q4 | $3.82M | Buy |
98,934
+76,834
| +348% | +$2.97M | 0.04% | 61 |
|
|
2024
Q3 | $995K | Buy |
+22,100
| New | +$995K | 0.02% | 171 |
|
|
2023
Q3 | – | Sell |
-19,140
| Closed | -$529K | – | 727 |
|
|
2023
Q2 | $529K | Buy |
19,140
+18,897
| +7,777% | +$522K | 0.01% | 187 |
|
|
2023
Q1 | $5.59K | Sell |
243
-39,757
| -99% | -$914K | ﹤0.01% | 321 |
|
|
2022
Q4 | $436K | Hold |
40,000
| – | – | 0.01% | 229 |
|
|
2022
Q3 | $337K | Buy |
40,000
+29,600
| +285% | +$249K | ﹤0.01% | 278 |
|
|
2022
Q2 | $82K | Sell |
10,400
-59,600
| -85% | -$470K | ﹤0.01% | 410 |
|
|
2022
Q1 | $1.66M | Sell |
70,000
-122,702
| -64% | -$2.9M | 0.02% | 188 |
|
|
2021
Q4 | $6.59M | Buy |
192,702
+82,702
| +75% | +$2.83M | 0.07% | 69 |
|
|
2021
Q3 | $1.95M | Buy |
+110,000
| New | +$1.95M | 0.02% | 163 |
|